Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to Ewing's sarcoma

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 10, 2012, Pages 1236-1240

  Yang, Shufeng ^a   Wang, Chaoyang ^b   Zhou, Yujia ^c   Sun, Guojing ^d   Zhu, Dongmei ^a   Gao, Suning ^a  

^a The 81st Hospital of PLA   (China)

^b 98th Hospital of PLA   (China)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d JINLING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA;

ADOLESCENT; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CHILD; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; EWING SARCOMA; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHILD; CTLA-4 ANTIGEN; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOMA, EWING; YOUNG ADULT;

EID: 84867494092     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0129     Document Type: Article

References (17)

1. Bouqbis L, Izaabel H, Akhayat O, et al. (2003) Association of the CTLA-4 promoter region (-1661G alleles) with type 1 diabetes in the south Moroccan population. Genes Immun 4:132-137.
2. Carvajal R, Meyers P (2005) Ewing's sarcoma and primitive neuroectodermal family of tumors. Hematol Oncol Clin North Am 19:501-525.
3. Delattre O, Zucman J, Plougastel B, et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162-165.
4. Egen JG, Kuhns MS, Allison JP (2002) CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3:611-618.
5. Erfani N, Razmkhah M, Talei AR, et al. (2006) Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet 165:114-120.
6. Hadinia A, Hossieni SV, Erfani N, et al. (2007) CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. J Gastroenterol Hepatol 22:2283-2287.
7. Ligers A, Teleshova N, Masterman T, et al. (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:145-152.
8. Liu Y, He Z, Feng D, et al. (2011) Cytotoxic T-lymphocyte anti-gen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol 30:1051-1055.
9. Karosas AO (2010) Ewing's sarcoma. Am J Health Syst Pharm 67:1599-1605.
10. Shi YY, He L (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15:97-98.
11. Teft WA, Kirchhof MG, Madrenas J (2006) A molecular perspective of CTLA-4 function. Annu Rev Immunol 24:65-97.
12. Turc-Carel C, Aurias A, Mugneret F, et al. (1988) Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 32:229-238.
13. Ueda H, Howson JM, Esposito L, et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506-511.
14. Wang J, Zhou Y, Feng D, et al. (2012) CD86+ 1057G/A polymorphism and susceptibility to Ewing's sarcoma: a case-control study. DNA Cell Biol 2012 31:537-540.
15. Wang W, Song H, Liu J, et al. (2011) CD86+ 1057G/A polymorphism and susceptibility to osteosarcoma. DNA Cell Biol 30:925-929.
16. Wong YK, Chang KW, Cheng CY, et al. (2006) Association of CTLA-4 gene polymorphism with oral squamous cell carcinoma. J Oral Pathol Med 35:51-54.
17. Xiao M, Qi F, Chen X, et al. (2010). Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carci-noma susceptibility in a Chinese population. Int J Immuno-genet 37:27-32.